Delivery Order SPE2DB24D9155-SPE2DB24FHZEX

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,326.26 firm fixed-price contract is for the delivery of 4,568,012,843 units of Botox 100 unit vials, with a completion date of May 12, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Botox 100 unit vials. The contract is a firm fixed-price, indefinite delivery contract with a ceiling value of $11,101.68 and a period of performance through May 20, 2025. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that has secured a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4,556,763,691 units of Botox 100 unit vials, with a total ceiling value of $44,087.00. The contract has a firm fixed price pricing type and a completion date of April 19, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,306.64 firm fixed-price contract is for the delivery of 100-unit vials of Botox to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Botox 100 unit vials, with a ceiling value of $2,312.85 and a period of performance through May 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at $499,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Botox 200-unit vials, with a ceiling value of $1,940.55 and a completion date of March 1, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,384.44, is for the delivery of BOTOX 100 unit vials to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,625.70, is for the delivery of 4,568,196,664 units of Botox 100 unit vials. The contract is a firm fixed-price delivery order with a completion date of May 29, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D9155
    Indefinite Delivery Contract
  • SPE2DB24D9155-SPE2DB24FHZEX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Botox 100 unit vials, with a total ceiling value of $8,306.64 and a completion date of July 23, 2024.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The current delivery order is part of this larger IDC contract, which does not have a set-aside designation.

Through this and other prime vendor contracts, DMS Pharmaceutical Group provides a vast array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the U.S. Department of Defense and Department of Veterans Affairs to support the diverse medical needs of military personnel and their dependents.

Generated 9/30/24, 11:14 AM